Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Activity of sunitinib in esophageal cancer, melanoma and sarcoma
2008-000756-27Phase 2Completed
- Sponsor
- UZ Brussel
- Start
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of sunitinib in esophageal cancer, melanoma and Bone and soft tissue sarcoma (3 cohorts), sponsored by UZ Brussel. Primary endpoint: Objective response rate. Started Apr 2008; status: completed.
02
Drugs
sunitinib
03
Conditions
esophageal cancermelanomaBone and soft tissue sarcoma
Beyond the preview
Go deeper on 2008-000756-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000756-27.